These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11217914)

  • 1. Re: Dose proportionality of fluticosone proportionate hydrofluoroalkane pressurized metered dose inhalers (pMDIS) and comparability with chlorofluorocarbon pMDIS.
    Lipworth BJ
    Respir Med; 2001 Feb; 95(2):160-3. PubMed ID: 11217914
    [No Abstract]   [Full Text] [Related]  

  • 2. From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
    Kunka R; Andrews S; Pimazzoni M; Callejas S; Ziviani L; Squassante L; Daley-Yates PT
    Respir Med; 2000 Jun; 94 Suppl B():S10-6. PubMed ID: 10919680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in lung bioavailability between different propellants for fluticasone propionate.
    Wilson AM; Sims EJ; Orr LC; Lipworth BJ
    Lancet; 1999 Oct; 354(9187):1357-8. PubMed ID: 10533870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
    Tonnel AB; Bons J; Legendre M; Prud'Homme A; Bugnas B; Evano-Celli I; Stuart AM
    Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
    Cripps A; Riebe M; Schulze M; Woodhouse R
    Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability.
    Brindley A
    J Allergy Clin Immunol; 1999 Dec; 104(6):S221-6. PubMed ID: 10588978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers.
    Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
    Chest; 2002 Aug; 122(2):510-6. PubMed ID: 12171824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budesonide administered using chlorofluorocarbon and hydrofluoroalkane pressurized metered-dose inhalers: pharmacokinetics, pharmacodynamics and clinical equivalence.
    Singh D; Tutuncu A; Lohr I; Carlholm M; Polanowski T
    Int J Clin Pharmacol Ther; 2007 Sep; 45(9):485-95. PubMed ID: 17907591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma.
    Kim KT; Milgrom H; Yoon YK; Levy AL; Matz P; Welch MJ; Cahn A; Collins DA; Kathman S; Mehta R; Su SF; Kunka RL
    J Clin Pharmacol; 2008 Jan; 48(1):108-16. PubMed ID: 18094223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
    Perruchoud AP; Lundback B; Yigla M; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S35-41. PubMed ID: 10919684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids.
    Lumry WR; Conway MM; LaForce CF; Pearlman DS; Scott CA; Herje NE; Wu WW; Crim C
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):51-9. PubMed ID: 16440533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressurized metered dose inhalers: chlorofluorocarbon to hydrofluoroalkane transition-valve performance.
    Cummings RH
    J Allergy Clin Immunol; 1999 Dec; 104(6):S230-6. PubMed ID: 10588980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
    Ayres JG; Millar AB; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
    Edin HM; Andersen LB; Schoaf L; Scott-Wilson CA; Ho SY; Ortega HG
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrofluoroalkane mandate in effect January 1, 2009: Switch from chlorofluorocarbon- to hydrofluoroalkane-propelled inhalers requires active transition.
    Peters S
    Clin Cornerstone; 2009; 9(3):50-3. PubMed ID: 19781516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant.
    Mackie AE; McDowall JE; Ventresca P; Bye A; Falcoz C; Daley-Yates PT
    Clin Pharmacokinet; 2000; 39 Suppl 1():17-22. PubMed ID: 11140429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pressurized metered dose inhaler (pMDI) remains the most commonly prescribed device for the delivery of inhaled asthma medications.
    Braunstein G; Sharma R
    Respir Med; 2000 Jun; 94 Suppl B():S1-2. PubMed ID: 10919678
    [No Abstract]   [Full Text] [Related]  

  • 19. The rejuvenated pressurised metered dose inhaler.
    Bell J; Newman S
    Expert Opin Drug Deliv; 2007 May; 4(3):215-34. PubMed ID: 17489650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic ratio of hydrofluoroalkane and chlorofluorocarbon formulations of fluticasone propionate.
    Fowler SJ; Orr LC; Sims EJ; Wilson AM; Currie GP; McFarlane L; Lipworth BJ
    Chest; 2002 Aug; 122(2):618-23. PubMed ID: 12171841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.